Fortress Biotech, Inc.FBIONASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+499.7%
5Y CAGR+54.4%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+499.7%/yr
vs -71.6%/yr prior
5Y CAGR
+54.4%/yr
Recent acceleration
Acceleration
+571.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
8.8x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 81.33% |
| Q2 2025 | -63.43% |
| Q1 2025 | 18.39% |
| Q4 2024 | -23.76% |
| Q3 2024 | 20.49% |
| Q2 2024 | 24.01% |
| Q1 2024 | -86.43% |
| Q4 2023 | -42.56% |
| Q3 2023 | 72.54% |
| Q2 2023 | 14.88% |
| Q1 2023 | -7.75% |
| Q4 2022 | -7.69% |
| Q3 2022 | 0.38% |
| Q2 2022 | -7.73% |
| Q1 2022 | 23.76% |
| Q4 2021 | -24.19% |
| Q3 2021 | -16.49% |
| Q2 2021 | -42.78% |
| Q1 2021 | -23.51% |
| Q4 2020 | -5.47% |
| Q3 2020 | 9.27% |
| Q2 2020 | -17.97% |
| Q1 2020 | 29.14% |
| Q4 2019 | -34.79% |
| Q3 2019 | 10.87% |
| Q2 2019 | 22.44% |
| Q1 2019 | 6.90% |
| Q4 2018 | -24.18% |
| Q3 2018 | -11.05% |
| Q2 2018 | 25.68% |
| Q1 2018 | -22.77% |
| Q4 2017 | 14.62% |
| Q3 2017 | -40.57% |
| Q2 2017 | -31.95% |
| Q1 2017 | 8.63% |
| Q4 2016 | -18.41% |
| Q3 2016 | -7.33% |
| Q2 2016 | -0.30% |
| Q1 2016 | -19.52% |
| Q4 2015 | 30.14% |